Actiphage is the first diagnostic for tuberculosis that can detect live mycobacteria in a sample of blood or milk.
We are here to support the eradication of tuberculosis and related mycobacterial diseases through early-stage detection of carriers.
Findings of clinical trial of Actiphage presented at ECCMID 2022 – click here for more.
PBD Biotech Ltd
Link House, Elm Farm Park,
Great Green, Thurston,
Suffolk IP31 3SH,
United Kingdom
Registered Company Address
Ingenuity Centre,
University of Nottingham,
Innovation Park, Triumph Rd,
Nottingham NG7 2TU,
United Kingdom
Health Protection Scotland has launched a consultation on bovine tuberculosis diagnostic testing - but only the skin test? Why not the use of a blood test, pre-movement to keep Scotland OTF status by detecting early infection? @P_H_S_Official @BritishVets
Read MoreJohne's Disease is a ticking time bomb in the dairy herd, now Actiphage provides a pre-breeding blood test to stop its transmission. We explain the relevance of new research that proves the link between mycobacteria in the blood and the development of TB
Read MoreDelighted to be taking our Actiphage tuberculosis blood test to Zambia, in a collaborative project with @ZambartResearch, @LSHTM, @LeicResearch The aim is to test its sensitivity in a real world setting. #Tuberculosis #EndTB #InvestToEndTB
Read More
